India Pharma Outlook 2015: Accelerating growth to the next level: Moving up the value chain beyond Generics

Domestic sales improved in 2014, recovering from the slump in the 2013 caused by the market’s reaction to the new drug pricing policy.  In 2015, growth is expected to continue to be healthy, as the momentum continues and improving economic growth allow more spending on healthcare.